Published in Euro Surveill on March 05, 2009
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog (2011) 1.16
Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry (2013) 1.16
Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open (2011) 0.94
Human cytomegalovirus and autoimmune disease. Biomed Res Int (2014) 0.90
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol (2012) 0.90
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health (2012) 0.88
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection. J Virol (2015) 0.87
Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis (2014) 0.84
Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One (2014) 0.78
High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium. Facts Views Vis Obgyn (2012) 0.77
Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis (2010) 0.77
Are female daycare workers at greater risk of cytomegalovirus infection? A secondary data analysis of CMV seroprevalence between 2010 and 2013 in Hamburg, Germany. GMS Hyg Infect Control (2016) 0.77
Distribution of Cytomegalovirus Genotypes among Neonates Born to Infected Mothers in Islamabad, Pakistan. PLoS One (2016) 0.75
Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine (Baltimore) (2017) 0.75
Imaging the fetal central nervous system. Facts Views Vis Obgyn (2011) 0.75
Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy. Dtsch Arztebl Int (2017) 0.75
Prevalence of CMV infection among staff in a metropolitan children's hospital - occupational health screening findings. GMS Hyg Infect Control (2016) 0.75
Host genetics and susceptibility to congenital and childhood cytomegalovirus infection: a systematic review. Croat Med J (2016) 0.75
Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection. Front Microbiol (2016) 0.75
Acute Cytomegalovirus Hepatitis in an Immunocompetent Host as a Reason for Upper Right Abdominal Pain. Case Rep Gastroenterol (2016) 0.75
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog (2017) 0.75
The human cytomegalovirus glycoprotein pUL11 acts via CD45 to induce T cell IL-10 secretion. PLoS Pathog (2017) 0.75
Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med (1998) 2.60
A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity (1997) 2.49
A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J (1999) 2.30
Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med (1992) 2.29
Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med (1994) 2.13
Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol (1994) 1.89
Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol (2000) 1.85
Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol (1995) 1.77
Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J Gen Virol (1996) 1.33
A mouse model for cytomegalovirus infection. Curr Protoc Immunol (2001) 1.32
Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology (1998) 1.31
IFN-gamma is a prerequisite for optimal antigen processing of viral peptides in vivo. J Immunol (1997) 1.14
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis (1998) 1.00
Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice. J Chemother (2007) 1.00
[Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.99
Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill (2014) 0.95
Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol (1995) 0.95
Prevention of autoimmune lysis by T cells with specificity for a heat shock protein by antisense oligonucleotide treatment. Proc Natl Acad Sci U S A (1994) 0.84
MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Virus Genes (2000) 0.80
Efficient downregulation of major histocompatibility complex class I molecules in human epithelial cells infected with cytomegalovirus. J Gen Virol (2001) 0.79
Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.79
Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. Curr Top Microbiol Immunol (2002) 0.76
Background paper to the revised recommendation for hepatitis B vaccination of persons at particular risk and for hepatitis B postexposure prophylaxis in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.76
Association of myocardial infarction with mononuclear cell expression of the cytomegalovirus chemokine receptor US28 in patients with NIDDM. Exp Clin Cardiol (2001) 0.75
[Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.75
[University medical education in change]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.75
[University medicine in transition]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.75
[First centenary of A. v. Wassermann]. Rev Clin Esp (1966) 0.75
[Advanced therapy medicinal products : Scientific, medical, economic, and ethical aspects]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.75
[Outbreak management: Lessons to learn]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.75